Applied DNA Sciences (APDN) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Applied DNA Sciences Revenue Highlights


Latest Revenue (Y)

$13.37M

Latest Revenue (Q)

$797.52K

Main Segment (Y)

Clinical Laboratory Testing Services (Point-in-Time)

Main Geography (Y)

Americas

Applied DNA Sciences Revenue by Period


Applied DNA Sciences Revenue by Year

DateRevenueChange
2023-09-30$13.37M-26.43%
2022-09-30$18.17M101.25%
2021-09-30$9.03M367.40%
2020-09-30$1.93M-64.16%
2019-09-30$5.39M38.06%
2018-09-30$3.90M-17.85%
2017-09-30$4.75M13.49%
2016-09-30$4.19M-53.53%
2015-09-30$9.01M231.05%
2014-09-30$2.72M33.64%
2013-09-30$2.04M9.79%
2012-09-30$1.85M91.43%
2011-09-30$968.85K86.37%
2010-09-30$519.84K76.12%
2009-09-30$295.16K-66.19%
2008-09-30$873.01K616.05%
2007-09-30$121.92K545.08%
2006-09-30$18.90K100.00%
2005-09-30-100.00%
2004-09-30-100.00%
2003-09-30-100.00%
2001-12-31-100.00%
2000-12-31-100.00%
1999-12-31-100.00%
1998-12-31-100.00%
1997-12-31--

Applied DNA Sciences generated $13.37M in revenue during NA 2023, up -26.43% compared to the previous quarter, and up 342.46% compared to the same period a year ago.

Applied DNA Sciences Revenue by Quarter

DateRevenueChange
2024-06-30$797.52K-14.21%
2024-03-31$929.63K4.32%
2023-12-31$891.16K14.29%
2023-09-30$779.74K-73.27%
2023-06-30$2.92M-33.81%
2023-03-31$4.41M-16.25%
2022-12-31$5.26M47.86%
2022-09-30$3.56M-17.16%
2022-06-30$4.30M-30.11%
2022-03-31$6.15M47.57%
2021-12-31$4.17M37.04%
2021-09-30$3.04M78.77%
2021-06-30$1.70M-36.35%
2021-03-31$2.67M65.30%
2020-12-31$1.62M414.71%
2020-09-30$313.99K-27.24%
2020-06-30$431.52K-21.89%
2020-03-31$552.47K-12.79%
2019-12-31$633.52K-62.13%
2019-09-30$1.67M-18.54%
2019-06-30$2.05M163.78%
2019-03-31$778.47K-11.97%
2018-12-31$884.32K-26.02%
2018-09-30$1.20M17.61%
2018-06-30$1.02M-2.64%
2018-03-31$1.04M61.18%
2017-12-31$647.68K-43.46%
2017-09-30$1.15M-36.27%
2017-06-30$1.80M98.52%
2017-03-31$905.37K0.26%
2016-12-31$903.01K-44.81%
2016-09-30$1.64M150.59%
2016-06-30$652.90K13.88%
2016-03-31$573.32K-56.70%
2015-12-31$1.32M-66.73%
2015-09-30$3.98M75.52%
2015-06-30$2.27M49.31%
2015-03-31$1.52M22.30%
2014-12-31$1.24M92.37%
2014-09-30$645.53K-23.26%
2014-06-30$841.20K32.03%
2014-03-31$637.15K6.66%
2013-12-31$597.35K-18.07%
2013-09-30$729.11K13.07%
2013-06-30$644.84K87.12%
2013-03-31$344.61K8.48%
2012-12-31$317.67K9.23%
2012-09-30$290.81K-44.98%
2012-06-30$528.57K1.96%
2012-03-31$518.40K0.29%
2011-12-31$516.90K84.03%
2011-09-30$280.88K22.28%
2011-06-30$229.71K63.56%
2011-03-31$140.44K-55.81%
2010-12-31$317.82K254.47%
2010-09-30$89.66K-47.32%
2010-06-30$170.19K-9.12%
2010-03-31$187.28K157.55%
2009-12-31$72.72K19.22%
2009-09-30$60.99K166.05%
2009-06-30$22.93K-64.55%
2009-03-31$64.67K-55.88%
2008-12-31$146.57K-49.35%
2008-09-30$289.42K14.53%
2008-06-30$252.69K-
2008-03-31$252.69K-

Applied DNA Sciences generated $797.52K in revenue during Q3 2024, up -14.21% compared to the previous quarter, and up 18.09% compared to the same period a year ago.

Applied DNA Sciences Revenue Breakdown


Applied DNA Sciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceSep 23Sep 22Sep 21Sep 20Sep 19
Research and Development Services (Over-Time)$421.58K----
Supply Chain$827.60K$38.58K$1.44M--
Asset Marking$311.81K$400.49K$587.01K--
Clinical Laboratory Testing Services (Over-Time)$3.54M----
Clinical Laboratory Testing Services (Point-in-Time)$7.61M----
Large Scale DNA Production$653.01K----
Supply chain-$887.06K$1.00M--
Asset marking-$534.59K$458.41K--
Clinical laboratory testing services (over-time)-$5.13M---
Clinical laboratory testing services (point-in-time)-$10.40M$4.79M--
Research and development services (over-time)-$592.00K$799.72K--
Diagnostic kits--$1.97M--
Research And Development Services---$1.13M$2.98M
Clinical Laboratory Testing Services---$81.95K-
Large Scale Dna Production---$281.97K$388.01K

Applied DNA Sciences's latest annual revenue breakdown by segment (product or service), as of Sep 23: Clinical Laboratory Testing Services (Point-in-Time) (56.95%), Clinical Laboratory Testing Services (Over-Time) (26.49%), Supply Chain (6.19%), Large Scale DNA Production (4.89%), Research and Development Services (Over-Time) (3.15%), and Asset Marking (2.33%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Large Scale DNA Production$258.15K-$271.88K$253.63K$127.51K---------------
Supply Chain$275.26K$467.49K$145.38K$242.83K$27.64K$411.76K$23.95K$67.06K$32.94K$2.90K$4.36K$12.65K$18.67K$1.03M$161.93K-----
Research and Development Services (Over-Time)$65.20K$77.53K$72.00K$135.62K$87.91K$126.06K--------------
Asset Marking$9.44K$9.44K$39.03K$92.31K$97.34K$83.13K$113.72K$140.17K$151.76K$97.23K$83.53K$110.70K$108.57K$117.98K$140.56K-----
Clinical Laboratory Testing Services (Over-Time)$324.58K$324.58K$509.11K$653.38K$938.08K$1.44M--------------
Clinical Laboratory Testing Services (Point-in-Time)$6.44K$12.12K$14.22K$1.52M$3.00M$3.07M--------------
Clinical laboratory testing services (point-in-time)------$1.69M$2.51M$4.33M$1.87M$1.64M---------
Clinical laboratory testing services (over-time)------$1.26M$1.39M$1.16M$1.33M----------
Asset marking------$154.56K$127.08K$141.66K$105.52K$72.25K---------
Supply chain------$316.81K$43.24K$115.46K$411.55K$879.30K---------
Research and development services (over-time)------$119.46K$152.73K$219.90K$105.69K$213.43K---------
Diagnostic test kits--------$180.02K$342.82K----------
Diagnostic kits----------$384.91K---------
Clinical Laboratory Testing Services-----------$826.61K$1.55M$772.77K------
Diagnostic Kits-----------$494.27K$724.59K$394.96K------
Equipment Lease Services Overtime-----------$43.96K$60.09K-------
Large Scale Dna Production--------------$-1.00-$142.53K$139.44K$204.90K$142.52K
Research And Development Services-----------$197.81K$124.76K$263.71K$131.91K$343.62K$286.60K$366.83K$318.40K$1.61M
Product And Authentication Services--------------------

Applied DNA Sciences's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Clinical Laboratory Testing Services (Over-Time) (34.56%), Supply Chain (29.31%), Large Scale DNA Production (27.49%), Research and Development Services (Over-Time) (6.94%), Asset Marking (1.01%), and Clinical Laboratory Testing Services (Point-in-Time) (0.69%).

Applied DNA Sciences Revenue Breakdown by Country

Annual Revenue by Country

CountrySep 23Sep 22Sep 21Sep 20Sep 19
Europe$258.36K$448.85K$359.51K$266.70K$600.37K
Asia and other$886.44K$175.39K$147.89K--
Americas$12.22M$17.54M---
United States--$8.52M--
Asia And Other---$499.48K$622.40K
U---$1.17M$4.17M

Applied DNA Sciences's latest annual revenue breakdown by geography, as of Sep 23: Americas (91.44%), Asia and other (6.63%), and Europe (1.93%).

Quarterly Revenue by Country

CountryDec 19Sep 19Jun 19Mar 19Dec 18Sep 18Jun 18Mar 18
U$393.49K$2.68M------
Asia And Other$170.79K$-1.12M$1.36M$221.75K$166.44K$52.77K$213.14K$433.72K
Europe$69.24K$110.30K$117.71K$221.69K$150.67K$205.45K$228.41K$378.83K
UNITED STATES--$580.25K$335.03K$567.22K$937.14K$574.80K$231.39K

Applied DNA Sciences's latest quarterly revenue breakdown by geography, as of Dec 19: U (62.11%), Asia And Other (26.96%), and Europe (10.93%).

Applied DNA Sciences Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
FONRFONAR$102.88B$25.94M
GTHGenetron$650.71M$201.32M
BNRBurning Rock Biotech$537.43M$125.62M
OLKOlink AB (publ)$169.91M$28.59M
PSNLPersonalis$73.48M$22.58M
STIMNeuronetics$71.35M$16.45M
TRIBTrinity Biotech$56.83M$14.70M
XGNExagen$52.55M$15.06M
BDSXBiodesix$49.09M$18.15M
PREPrenetics Global$21.74M$6.41M
DRIODarioHealth$20.35M$6.25M
APDNApplied DNA Sciences$13.37M$797.52K
ISPCiSpecimen$9.93M$2.86M
OCXOncoCyte$1.50M$115.00K
MYNZMainz Biomed B.V.$895.48K$214.76K
SERASera Prognostics$306.00K$24.00K

APDN Revenue FAQ


What is Applied DNA Sciences’s yearly revenue?

Applied DNA Sciences's yearly revenue for 2023 was $13.37M, representing a decrease of -26.43% compared to 2022. The company's yearly revenue for 2022 was $18.17M, representing an increase of 101.25% compared to 2021. APDN's yearly revenue for 2021 was $9.03M, representing an increase of 367.40% compared to 2020.

What is Applied DNA Sciences’s quarterly revenue?

Applied DNA Sciences's quarterly revenue for Q3 2024 was $797.52K, a -14.21% decrease from the previous quarter (Q2 2024), and a -72.66% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $929.63K, a 4.32% increase from the previous quarter (Q1 2024), and a -78.91% decrease year-over-year (Q2 2023). APDN's quarterly revenue for Q1 2024 was $891.16K, a 14.29% increase from the previous quarter (Q4 2023), and a -83.07% decrease year-over-year (Q1 2023).

What is Applied DNA Sciences’s revenue growth rate?

Applied DNA Sciences's revenue growth rate for the last 3 years (2021-2023) was 48.07%, and for the last 5 years (2019-2023) was 148.05%.

What are Applied DNA Sciences’s revenue streams?

Applied DNA Sciences's revenue streams in p 23 are Research and Development Services (Over-Time), Supply Chain, Asset Marking, Clinical Laboratory Testing Services (Over-Time), Clinical Laboratory Testing Services (Point-in-Time), and Large Scale DNA Production. Research and Development Services (Over-Time) generated $421.58K in revenue, accounting 3.15% of the company's total revenue Supply Chain generated $827.6K in revenue, accounting 6.19% of the company's total revenue, up 2045.33% year-over-year. Asset Marking generated $311.81K in revenue, accounting 2.33% of the company's total revenue, down -22.14% year-over-year. Clinical Laboratory Testing Services (Over-Time) generated $3.54M in revenue, accounting 26.49% of the company's total revenue Clinical Laboratory Testing Services (Point-in-Time) generated $7.61M in revenue, accounting 56.95% of the company's total revenue Large Scale DNA Production generated $653.02K in revenue, accounting 4.89% of the company's total revenue

What is Applied DNA Sciences’s main source of revenue?

For the fiscal year ending Sep 23, the largest source of revenue of Applied DNA Sciences was Clinical Laboratory Testing Services (Point-in-Time). This segment made a revenue of $7.61M, representing 56.95% of the company's total revenue.